VGA1155

 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Benzoates

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
The novel VEGF receptor antagonist, VGA1155, reduces edema, decreases infarct and improves neurological function after stroke in rats.
Vascular endothelial growth factor (VEGF) is a major mediator of angiogenesis and also a strong vascular permeability factor… (More)
  • table I
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2010
2010
The Novel VEGF Receptor Antagonist , VGA 1155 , Reduces Edema , Decreases Infarct and Improves Neurological Function after Stroke in Rats JUNJI KOYAMA * , SHIGERU MIYAKE , TAKASHI SASAYAMA…
Vascular endothelial growth factor (VEGF) is a major mediator of angiogenesis and also a strong vascular permeability factor… (More)
Is this relevant?
2008
2008
Anti-VEGF receptor antagonist (VGA1155) reduces infarction in rat permanent focal brain ischemia.
BACKGROUND AND PURPOSE Vascular endothelial growth factor (VEGF) is a major mediator of angiogenesis and a strong vascular… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2008
2008
Anti-VEGF receptor antagonist (VGA1155) reduces infarction in rat permanent focal brain ischemia
 
Is this relevant?
2007
2007
Effect of VEGF receptor antagonist (VGA1155) on brain edema in the rat cold injury model
 
Is this relevant?
2007
2007
Effect of VEGF receptor antagonist (VGA1155) on brain edema in the rat cold injury model.
Vascular endothelial growth factor (VEGF) is a major mediator of angiogenesis and a strong vascular permeability factor. Blockade… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2005
2005
Antitumor effects of synthetic VEGF-receptor binding antagonist, VGA1155.
Vascular endothelial growth factor (VEGF) plays key roles in tumor angiogenesis. Therefore, VEGF and its receptors are considered… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2004
2004
VGA1155, a novel binding antagonist of VEGF, inhibits angiogenesis in vitro and in vivo.
The process of angiogenesis involves the formation of new blood vessels from established vasculature and is essential for… (More)
Is this relevant?
2003
2003
A novel low molecular weight antagonist of vascular endothelial growth factor receptor binding: VGA1155.
Vascular endothelial growth factor (VEGF) plays a pivotal role in the processes of angiogenesis, which is essential for the… (More)
  • figure 1
  • figure 2
  • figure 4
  • figure 3
  • table 1
Is this relevant?